Nasdaq Uplisting Update The Company issued its audited financial statements for both 2024 and 2025 during the first quarter of 2026. The Company plans to continue moving forward with the next steps ...

BioStem Technologies, Inc. (BSEM) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.17 per share a year ago.

BioStem’s management is scheduled to present on Monday, May 18, 2026, at 1:30 PM ET. Interested parties may access live and archived webcasts of the presentations on the “investors” section of the ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. With no fresh headline event driving attention to BioStem Technologies (BSEM), recent ...

POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE)-- BioStem Technologies (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of ...

Ungrodt brings nearly three decades of financial leadership to the role, having spent her career as a senior partner at Ernst & Young advising life sciences companies on initial and secondary public ...

POMPANO BEACH, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem”, “we”, “us”, or “our”), a leading MedTech ...

BioStem Technologies Inc. Annual cash flow by MarketWatch. View BSEM net cash flow, operating cash flow, operating expenses and cash dividends.

POMPANO BEACH, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...

BioStem Technologies announced Tuesday morning that it is acquiring the majority of Auxocell Laboratories’ assets. BioStem is a company which utilizes perinatal tissue in the “development, ...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024 Achieves preliminary GAAP net income of $15.5 million, or ...